ArisGlobal Announces XDI NavaX Data Intelligence, Three New Agents, and NavaX Translation

ArisGlobal, an AI-first technology company at the forefront of life sciences and the developer of LifeSphere, announced five important new products to advance the cross-functional operationalization of AI. On the first day of Breakthrough 2026, the company’s annual industry event, the company announced XDI, a next-generation data intelligence cortex, three new AI agents, and NavaX Translation for PV case data ingestion workflows.

XDI ArisGlobal’s next-generation data intelligence cortex accesses data from multiple functions and systems to enable consistent and explainable decision-making within and across pharmaceutical R&D enterprises. Unlike tools that simply accelerate steps within a single workflow, XDI creates a system-agnostic foundation that unifies meaning, context, and intent, ensuring decisions across safety, regulatory, clinical, quality, manufacturing, and all other functions are based on shared meaning, consistent evidence, and unified governance. This accelerates AI adoption and operationalization with confidence, while reducing risk and misinterpretation across teams and use cases.

New agents for regulatory intelligence, change distribution, and signals

ArisGlobal has also expanded its NavaX Agents Suite portfolio with three powerful new agents.

• intelligence officer Transform the quality of your submissions by automatically interpreting regulatory guidelines, converting them into accurate rules checklists, and evaluating documents from LifeSphere submissions with clear compliance ratings, legitimacy, and confidence scores.
• distributor Achieve continuous compliance validation by automatically consuming evolving regulatory guidelines, validating them against internal distribution logic, and triggering managed change workflows when discrepancies occur.
• signal agent is an intelligent assistant that interprets user intent, determines the best analytical approach, and dynamically plans and executes workflows. As an active intelligence partner, we leverage reasoning-based orchestration layers across safety, data, analytics, and expert judgment.

Also read: AiThority interview with Zohaib Ahmed, co-founder and CEO of Resemble AI

NavaX translation – Transforming global case data ingestion workflows

Through a strategic partnership with TransPerfect Life Sciences, ArisGlobal now supports certified translation capabilities integrated directly into case data ingestion workflows. Intelligent language detection instantly routes non-English safety forms and translates them using pharma-specific language models and expert linguists. Seamless API integration returns translated forms directly to LifeSphere, eliminating manual intervention and dramatically accelerating global pharmacovigilance. The combination of NavaX and TransPerfect reduces translation management time from approximately 5 hours to less than 1 minute per translation, delivering automation, speed, and accuracy unmatched on the market.

“The challenge for life sciences is not just deploying AI; it’s operationalizing AI at scale with consistency, governance, and real business impact. With these latest product enhancements, we continue to enable organizations to move from experiment to production and transform AI into a trusted foundation for enterprise decision-making,” commented Aman Wasan, CEO of ArisGlobal.

“We are witnessing a fundamental shift in the way technology powers life sciences teams. These innovations represent an evolution away from automation.” individual task to Coordinating intelligence across the operational ecosystemThis enables smarter decisions, faster insights, and truly scalable AI deployments,” said Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal.

Breakthrough 2026 in Madrid, Spain will bring together top executives, industry leaders, and experts to explore the theme of “Operationalizing AI” and showcase how proven AI use cases are transforming into everyday practice across the life sciences.